Literature DB >> 16620185

Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women.

R A Brownbill1, J Z Ilich.   

Abstract

BACKGROUND: Previous studies suggest a relationship between cardiovascular disease (CVD) and osteoporosis; however, the mechanism of the relationship and whether serum lipids are positively or negatively associated with bone mineral density (BMD) are unclear.
METHODS: We investigated the relationship among serum lipids, dietary saturated fat, BMD of various skeletal sites, and markers of bone turnover. This was a cross-sectional analysis in 136 Caucasian, healthy, postmenopausal women, who were not taking lipid-lowering medications or drugs affecting bone metabolism. BMD at multiple skeletal sites was assessed by DXA. Concentration of serum triglycerides, cholesterol, osteocalcin (OC), and undercarboxylated osteocalcin (UOC) and urinary cross-linked N-telopeptides were analyzed by routine methods. Saturated fat, total calcium (food and supplements), total vitamin K, alcohol, and energy intake were estimated using 3-day dietary records. Physical activity was assessed and used as a confounder with other anthropometric measurements.
RESULTS: Serum triglycerides were positively related to femoral shaft BMD and serum cholesterol to total body BMD (p < 0.05). Also, subjects with serum triglycerides above the median had significantly higher BMD in femoral Ward's triangle than those below the median (p = 0.037, by ANCOVA). Subjects with a serum cholesterol level of > or =240 mg/dL (cutoff for increased risk for CVD) had significantly higher BMD at the total body and at all sites of the femur (except neck). There was no relationship between serum lipids and markers of bone turnover. Saturated fat intake was not associated with BMD of any skeletal site.
CONCLUSIONS: These findings indicate that higher levels of serum triglycerides and cholesterol are positively associated with BMD of various skeletal sites. The mechanism of this association is not clear, and studies are needed to clarify this relationship.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16620185     DOI: 10.1089/jwh.2006.15.261

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  29 in total

Review 1.  Bone and glucose metabolism: a two-way street.

Authors:  Katherine J Motyl; Laura R McCabe; Ann V Schwartz
Journal:  Arch Biochem Biophys       Date:  2010-08-01       Impact factor: 4.013

Review 2.  Should we abandon statins in the prevention of bone fractures?

Authors:  Katherine Esposito; Annalisa Capuano; Liberata Sportiello; Andrea Giustina; Dario Giugliano
Journal:  Endocrine       Date:  2013-03-24       Impact factor: 3.633

3.  Association of interleukin-1 beta (-511C/T) polymorphisms with osteoporosis in postmenopausal women.

Authors:  Tai-Hung Chao; Hsing-Ning Yu; Chi-Chuan Huang; Wen-Shen Liu; Ya-Wen Tsai; Wen-Tung Wu
Journal:  Ann Saudi Med       Date:  2010 Nov-Dec       Impact factor: 1.526

4.  Association of lipid parameters and insulin resistance with bone health in South Korean adolescents.

Authors:  S-W Park; G-E Nam; D-W Jung; S-J Yoon; K Han; Y-G Park; J-S Choi; J-E Lee; J-E Sang; Y-J Yoon; D-H Kim
Journal:  Osteoporos Int       Date:  2015-09-02       Impact factor: 4.507

5.  PPARG by dietary fat interaction influences bone mass in mice and humans.

Authors:  Cheryl L Ackert-Bicknell; Serkalem Demissie; Caralina Marín de Evsikova; Yi-Hsiang Hsu; Victoria E DeMambro; David Karasik; L Adrienne Cupples; Jose M Ordovas; Katherine L Tucker; Kelly Cho; Ernesto Canalis; Beverly Paigen; Gary A Churchill; Jiri Forejt; Wesley G Beamer; Serge Ferrari; Mary L Bouxsein; Douglas P Kiel; Clifford J Rosen
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

6.  Diet and gene interactions influence the skeletal response to polyunsaturated fatty acids.

Authors:  Nicolas Bonnet; Emmanuel Somm; Clifford J Rosen
Journal:  Bone       Date:  2014-08-01       Impact factor: 4.398

7.  Decreased bone mineral density in subjects carrying familial defective apolipoprotein B-100.

Authors:  Laura M Yerges-Armstrong; Haiqing Shen; Kathleen A Ryan; Elizabeth A Streeten; Alan R Shuldiner; Braxton D Mitchell
Journal:  J Clin Endocrinol Metab       Date:  2013-10-08       Impact factor: 5.958

8.  Maternal Flaxseed Oil During Lactation Enhances Bone Development in Male Rat Pups.

Authors:  Aline D'Avila Pereira; Danielle Cavalcante Ribeiro; Fernanda Carvalho de Santana; Aline de Sousa Dos Santos; Jorge Mancini-Filho; Celly Cristina Alves do Nascimento-Saba; Luis Guillermo Coca Velarde; Carlos Alberto Soares da Costa; Gilson Teles Boaventura
Journal:  Lipids       Date:  2016-06-02       Impact factor: 1.880

Review 9.  Effects of bioactive lipids and lipoproteins on bone.

Authors:  Yin Tintut; Linda L Demer
Journal:  Trends Endocrinol Metab       Date:  2013-10-30       Impact factor: 12.015

10.  Lipid profile, obesity and bone mineral density: the Hertfordshire Cohort Study.

Authors:  E M Dennison; H E Syddall; A Aihie Sayer; H J Martin; C Cooper
Journal:  QJM       Date:  2007-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.